Focus Partners Wealth Portfolio holdings
AUM
$46.1B
1-Year Return
15.84%
This Quarter Return
+9.29%
1 Year Return
+15.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$46.1B
AUM Growth
+$6.24B
(+16%)
Cap. Flow
+$3.23B
Cap. Flow
% of AUM
7%
Top 10 Holdings %
Top 10 Hldgs %
20.23%
Holding
2,136
New
257
Increased
1,141
Reduced
547
Closed
120
Top Buys
| 1 |
Dimensional US High Profitability ETF
DUHP
|
$249M |
| 2 |
Dimensional International High Profitability ETF
DIHP
|
$193M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$171M |
| 4 |
Avantis US Equity ETF
AVUS
|
$160M |
| 5 |
Apple
AAPL
|
$118M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
$232M |
| 2 |
RTX Corp
RTX
|
$100M |
| 3 |
Dimensional US Marketwide Value ETF
DFUV
|
$63.8M |
| 4 |
Vanguard Short-Term Treasury ETF
VGSH
|
$44.4M |
| 5 |
iShares Morningstar Small-Cap Growth ETF
ISCG
|
$40.9M |
Sector Composition
| 1 | Technology | 13.41% |
| 2 | Financials | 7.18% |
| 3 | Consumer Discretionary | 4.63% |
| 4 | Communication Services | 3.85% |
| 5 | Healthcare | 3.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1951
Milestone Pharmaceuticals
MIST
$149M
| $69.8K | ﹤0.01% |
+36,000
| New | +$69.8K |
|
1952
Relay Therapeutics
RLAY
$700M
| $68K | ﹤0.01% |
+19,647
| New | +$68K |
|
|
NGD
1953
New Gold Inc
NGD
$5.16B
| $64.6K | ﹤0.01% |
13,052
+494
| +4% | +$2.45K |
|
1954
Anixa Biosciences
ANIX
$96M
| $60.2K | ﹤0.01% |
18,243
-53,559
| -75% | -$177K |
|
1955
Blend Labs
BLND
$1.13B
| $60.2K | ﹤0.01% |
+18,237
| New | +$60.2K |
|
1956
Transocean
RIG
$2.98B
| $58.9K | ﹤0.01% |
22,731
+8,931
| +65% | +$23.1K |
|
1957
Monte Rosa Therapeutics
GLUE
$296M
| $57.7K | ﹤0.01% |
12,789
+801
| +7% | +$3.61K |
|
1958
Tronox
TROX
$717M
| $57.5K | ﹤0.01% |
+11,335
| New | +$57.5K |
|
1959
Arbutus Biopharma
ABUS
$784M
| $55.1K | ﹤0.01% |
17,821
-191
| -1% | -$590 |
|
1960
Ardelyx
ARDX
$1.59B
| $54.6K | ﹤0.01% |
13,935
-695
| -5% | -$2.72K |
|
1961
Petco
WOOF
$1.06B
| $54.6K | ﹤0.01% |
19,287
+6,285
| +48% | +$17.8K |
|
|
TSI
1962
TCW Strategic Income Fund
TSI
$238M
| $50.7K | ﹤0.01% |
10,275
| – | – |
|
1963
Plug Power
PLUG
$1.66B
| $50.5K | ﹤0.01% |
33,900
+6,333
| +23% | +$9.44K |
|
|
SVM
1964
Silvercorp Metals
SVM
$1.09B
| $49.7K | ﹤0.01% |
11,781
-2,219
| -16% | -$9.36K |
|
1965
scPharmaceuticals
SCPH
$300M
| $49.2K | ﹤0.01% |
+12,923
| New | +$49.2K |
|
1966
Akebia Therapeutics
AKBA
$830M
| $48.3K | ﹤0.01% |
13,267
+1,876
| +16% | +$6.83K |
|
1967
BARK
BARK
$155M
| $47.6K | ﹤0.01% |
+54,171
| New | +$47.6K |
|
1968
Ambev
ABEV
$34.3B
| $46.3K | ﹤0.01% |
19,224
+5,012
| +35% | +$12.1K |
|
1969
Editas Medicine
EDIT
$251M
| $45.8K | ﹤0.01% |
20,812
+2,062
| +11% | +$4.54K |
|
1970
Atlantic American Corp
AAME
$65.7M
| $39.1K | ﹤0.01% |
18,335
| – | – |
|
1971
Nordic American Tanker
NAT
$688M
| $38.1K | ﹤0.01% |
+14,500
| New | +$38.1K |
|
|
NNDM
1972
Nano Dimension
NNDM
$313M
| $38.1K | ﹤0.01% |
23,500
+2,000
| +9% | +$3.24K |
|
1973
Fate Therapeutics
FATE
$111M
| $36.6K | ﹤0.01% |
32,716
+2,515
| +8% | +$2.82K |
|
1974
Compass Therapeutics
CMPX
$590M
| $35.4K | ﹤0.01% |
13,599
-2
| -0% | -$5 |
|
1975
Sera Prognostics
SERA
$121M
| $33.7K | ﹤0.01% |
12,156
-11
| -0.1% | -$30 |
|